RO4602522
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for RO4602522, covering 2016-11-02 to 2017-05-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy [Phase 2]